Cargando…

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries

BACKGROUND: Time to reimbursement (TTR) of new anticancer medicines differs between countries and contributes to unequal access. We aimed to investigate TTR of new anticancer medicines and explore factors influencing the reimbursement process in seven high-income European countries. MATERIALS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Post, H.C., Schutte, T., van Oijen, M.G.H., van Laarhoven, H.W.M., Hollak, C.E.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163159/ https://www.ncbi.nlm.nih.gov/pubmed/37030113 http://dx.doi.org/10.1016/j.esmoop.2023.101208

Ejemplares similares

External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients
por: van Kleef, J.J., et al.
Publicado: (2020)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
por: Noordman, Janneke, et al.
Publicado: (2010)

How is intensive care reimbursed? A review of eight European countries
por: Bittner, Martin-Immanuel, et al.
Publicado: (2013)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
por: Stawowczyk, Ewa, et al.
Publicado: (2019)

Reimbursement measures in European countries – findings of a bibliometric literature review
por: Vogler, Sabine, et al.
Publicado: (2015)

Outcome-based reimbursement in Central-Eastern Europe and Middle-East
por: Ádám, Ildikó, et al.
Publicado: (2022)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019)

Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping
por: van Kessel, Robin, et al.
Publicado: (2023)

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
por: Kardas, Przemysław, et al.
Publicado: (2022)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
por: Ágh, Tamás, et al.
Publicado: (2022)

Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries
por: Quentin, Wilm, et al.
Publicado: (2011)

An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
por: Ward, Leanne Marie, et al.
Publicado: (2022)

The timing of introduction of pharmaceutical innovations in seven European countries
por: Westerling, Ragnar, et al.
Publicado: (2014)

Overview of harm reduction in prisons in seven European countries
por: Sander, Gen, et al.
Publicado: (2016)

Cost of youth tobacco-control policies in seven European countries
por: Leão, Teresa, et al.
Publicado: (2020)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

The Relationship Between Sociodemographics and Environmental Values Across Seven European Countries
por: Sargisson, Rebecca J., et al.
Publicado: (2020)

European citizens' use of E-health services: A study of seven countries
por: Andreassen, Hege K, et al.
Publicado: (2007)

Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
por: Rigter, Tessel, et al.
Publicado: (2021)

Children’s Independent Mobility to School in Seven European Countries: A Multinomial Logit Model
por: Masoumi, Houshmand, et al.
Publicado: (2020)

Culture and End of Life Care: A Scoping Exercise in Seven European Countries
por: Gysels, Marjolein, et al.
Publicado: (2012)

Acute myocardial infarction and diagnosis-related groups: patient classification and hospital reimbursement in 11 European countries
por: Quentin, Wilm, et al.
Publicado: (2013)

Associations between dietary patterns, FTO genotype and obesity in adults from seven European countries
por: Livingstone, Katherine M., et al.
Publicado: (2022)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer
por: Trumpi, K., et al.
Publicado: (2015)

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces
por: Kroon, M.A.G.M., et al.
Publicado: (2023)

Reimbursement for reconstruction by tissue transfer–a European comparison
por: Lotter, Oliver, et al.
Publicado: (2014)

Suicide methods in Europe: a gender-specific analysis of countries participating in the “European Alliance Against Depression”
por: Värnik, A, et al.
Publicado: (2008)

Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries
por: Enzing, Joost J., et al.
Publicado: (2022)

Social norms towards smoking and electronic cigarettes among adult smokers in seven European Countries: Findings from the EUREST-PLUS ITC Europe Surveys
por: East, Katherine A., et al.
Publicado: (2019)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2018)

The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
por: Kawalec, Paweł, et al.
Publicado: (2016)

Radiology education in Europe: Analysis of results from 22 European countries
por: Rehani, Bhavya, et al.
Publicado: (2017)

Coronary artery bypass grafts and diagnosis related groups: patient classification and hospital reimbursement in 10 European countries
por: Gaughan, James, et al.
Publicado: (2014)

Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries
por: Blonda, Alessandra, et al.
Publicado: (2022)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Smoking beliefs across genders, a comparative analysis of seven European countries
por: Grard, Adeline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_usme5hiq890joa41r1c1mbk7at